S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NKTR Nektar Therapeutics

0.831

0.0221 (2.73%)

Pre Market

Last Updated: 07:18:28

Delayed by 15 minutes

Form 5 - Annual statement of changes in beneficial ownership of securities

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics News

Form 5 - Annual statement of changes in beneficial ownership of securities
Friday 17 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
Friday 10 January 2025 (4 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 26 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 23 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

More Nektar Therapeutics News Articles

Super Micro Computer

Liquidmetal Technologies (QB)

MineralRite (PK)

Asia Broadband (PK)

NioCorp Developments

TPT Global Tech (CE)

Rennova Health (CE)

Tonix Pharmaceuticals

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions